We're proud to be working with our customer, @argonne
, and delivering low latency and deterministic performance–both mission-critical to #fusionenergy reactor operations and stability.
ENTERPRISE AI
-
Groq et Argonne collaborent pour optimiser les réacteurs de fusion
By
–
-
NVIDIA Isaac and DRIVE Sim Enable Rapid Robot and Vehicle Learning
By
–
With NVIDIA Isaac simulation technology, #robots can earn a PhD in the blink of an eye. And with NVIDIA DRIVE Sim, autonomous vehicles can drive millions of miles in a wide range of simulated scenarios so they navigate safely. Learn more: https://
nvda.ws/3xTkalW #NVIDIAstory -
H2O.ai and AT&T Partner on AI Feature Store Technology
By
–
http://
H2O.ai technology partner, @ATT discusses our co-created H2O AI Feature Store with @VentureBeat
. https://
venturebeat.com/ai/at-att-ai-i
s-becoming-part-of-core-fabric-says-chief-data-officer/
… -
AI Drug Discovery: Calibrating Expectations with Reality
By
–
#AI in drug discovery has incredible potential, but it remains hard and some of the hype may not be grounded in reality. Our CEO and founder @DaphneKoller spoke with @MaxGelman about why she believes the industry needs to calibrate people's expectations with what's possible. Endpoints News (@endpts) Despite a flood of companies entering the AI space, the field has little hard data to show for itself, at least as far as the public can see. And that begs the question: How much of the “AI revolution” is hype, and how much is grounded in reality? endpts.com/biopharma-has-hyp… — https://nitter.net/endpts/status/1496171266667073547#m
→ View original post on X — @daphnekoller, 2022-02-23 22:18 UTC
-
insitro Announces $400M Series C Financing for Drug Discovery
By
–
A major milestone in our journey, enabled by the many accomplishments of amazing insitrocytes and support of outstanding, long-term investors. We are excited to continue towards our goal of using #ML and data at scale to bring transformative #medicines to patients. https://t.co/XRGBVFoYMR
— Daphne Koller (@DaphneKoller) 16 mars 2021A major milestone in our journey, enabled by the many accomplishments of amazing insitrocytes and support of outstanding, long-term investors. We are excited to continue towards our goal of using #ML and data at scale to bring transformative #medicines to patients. insitro (@insitro) We're thrilled to announce our $400M Series C financing, which will greatly enable us to continue advancing our vision to reshape the discovery and development of transformative medicines by leveraging #machinelearning and biology and chemistry at scale. bwnews.pr/3eL7G7v — https://nitter.net/insitro/status/1371416831840374789#m
→ View original post on X — @daphnekoller, 2021-03-16 01:54 UTC